July 18, 2013

As summer fun winds down, families make preparations for return to school. For the retail clinician, summertime is back-to-school season. Sports physicals or pre-participation physical evaluation (i.e., PPE) represent an important service in the retail health setting and an important opportunity to impact the child’s health.

July 18, 2013

Almost twice as many drugs for neglected diseases have received regulatory approval around the world over the past few years compared with the beginning of the last decade, according to a new study.

July 18, 2013

Taro Pharmaceutical Industries has appointed Dilip Shanghvi as chairman, the Israeli generic drug maker said Thursday.

July 18, 2013

Millions of Americans struggle daily with the cost of their prescription drug medications, leading to drop-offs in adherence and, all too often, a reduction in health outcomes and quality of life.

July 18, 2013

The aging population, financial stress and the Patient Protection and Affordable Care Act has forced the entire medical delivery system into a game of musical chairs. The music has started, and each component of the healthcare delivery system is aggressively looking to have a chair.

July 17, 2013

Biomed Pharmaceuticals has appointed Gaston Bernstein as CEO, the maker of injectable and intravenous drugs for patients with chronic disorders said.

July 17, 2013

A federal court in New York has dismissed a lawsuit alleging that Mylan infringed four of Teva Pharmaceutical Industries' patents when it sought Food and Drug Administration approval for a multiple sclerosis drug.

July 17, 2013

New, abuse-deterrent formulations of two opioid painkillers have not necessarily reduced doctors' unease with prescribing them, according to a new study.

July 17, 2013

Avella Specialty Pharmacy has released a new white paper that it said would help oncologists select appropriate specialty pharmacies.

July 16, 2013

Diplomat Specialty Pharmacy is supporting a summer camp for children with chronic kidney disease, the company said Tuesday.

July 16, 2013

The Food and Drug Administration has approved a generic epilepsy and bipolar disorder drug made by Actavis, the drug maker said.

July 16, 2013

Men who took an erectile dysfunction drug made by Eli Lilly experienced normal erectile function when taking it once a day as opposed to taking erectile dysfunction treatment on an as-needed basis, according to a new study.

July 16, 2013

Mylan has launched a generic contraceptive therapy, the drug maker said Tuesday.

July 16, 2013

Pharmacists in Indiana want an active consultation role when customers purchase over-the-counter HIV tests, according to a new study.

July 16, 2013

Stop & Shop is expanding a program to educate children about nutrition, the Ahold USA-owned supermarket chain said.

July 15, 2013

The Food and Drug Administration has approved a generic opioid painkiller made by Actavis, the drug maker said.

July 15, 2013

Self-reported medication adherence rates increased among Type 2 diabetes patients using a mobile app, the maker of the app said Monday.

July 15, 2013

MinuteClinic has created a weight-loss program that incorporates what has been ranked as one of the top diets in the country.

July 15, 2013

Mylan has launched a generic drug for treating cholesterol problems, the company said Monday.

July 15, 2013

The National Association of Specialty Pharmacy will begin developing pharmacy practice parameters in about 20 specialty therapeutic categories this year, the group said.

July 15, 2013

A team of scientists at The Wistar Institute has determined that it might be possible to stimulate the immune system against multiple strains of influenza virus by sequentially vaccinating individuals with distinct influenza strains isolated over the last century, researchers announced Monday.

July 12, 2013

Actavis is looking to become the first to market a generic drug for epilepsy, the company said.

July 12, 2013

A developer of revenue and payment cycle management and clinical information exchange software is expanding its payment network.

July 12, 2013

The Food and Drug Administration has approved a new lung cancer drug made by Boehringer Ingelheim, the agency said.